Figure 2.
Feed intake.
Notes: (A) Feed intake in HAp-PEG-FA-PAC-treated male; *P<0.05, statistically significant when compared to control. (B) Feed intake in HAp-PEG-FA-PAC-treated female; *P<0.05, statistically significant when compared to control. (C) Feed intake in TiO2-PEG-FA-PAC-treated male; *P<0.05, statistically significant when compared to control. (D) Feed intake in TiO2-PEG-FA-PAC-treated female; *P<0.05, statistically significant when compared to control.
Abbreviations: HAp-PEG-FA-PAC, surface modified paclitaxel attached hydroxyapatite; TiO2-PEG-FA-PAC, surface modified paclitaxel attached titanium dioxide.